⏳
Showing Q3 2024 data
Athyrium Capital Management, LP's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Athyrium Capital Management, LP
•CIK: 1728001•Filing: Q3 2024
Athyrium Capital Management, LP is a focused, multi-strategy manager currently overseeing $9M in assets. The firm maintains a concentrated portfolio, evidenced by its two primary holdings. Top positions include a significant allocation to UBS, representing $5.5M, and a substantial stake in PBYI at $3.2M. This structure suggests a targeted approach emphasizing established financial institutions and specific sector plays.
Total AUM
$8.7M
QoQ Performance
-23.2%
Positions
2
Top 10 Concentration
100.0%
Latest Filing
Q3 2024
Top Holdings Allocation
Bior
PBYI
Biora63.1%
PBYI36.9%
📈 Biggest Buys
No new positions or increases this quarter
📉 Biggest Sells
No reductions this quarter
Sector Breakdown
Other100.0%
Historical Filings
Q3 2024Q2 2024Q1 2024Q4 2023